Athira Pharma
ATHA
ATHA
98 hedge funds and large institutions have $68M invested in Athira Pharma in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
18% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 28
81% less capital invested
Capital invested by funds: $354M → $68M (-$286M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
98
Holding in Top 10
–
Calls
$13.1M
Puts
$5.04M
Top Buyers
| 1 | +$5.73M | |
| 2 | +$4.18M | |
| 3 | +$1.53M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$715K |
| 5 |
Two Sigma Investments
New York
|
+$641K |
Top Sellers
| 1 | -$26.6M | |
| 2 | -$25.7M | |
| 3 | -$17.2M | |
| 4 |
VA
VR Adviser
New York
|
-$13.5M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$7.89M |